Atara Biotherapeutics, Inc.

NasdaqGS:ATRA Stock Report

Market Cap: US$85.3m

Atara Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ATRA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Mar 24SellUS$2,793Jill HenrichIndividual3,879US$0.72
04 Mar 24SellUS$17,888Pascal TouchonIndividual24,844US$0.72
04 Mar 24SellUS$4,810Eric HyllengrenIndividual6,679US$0.72
04 Mar 24SellUS$7,232K. MuruganIndividual10,044US$0.72
04 Mar 24SellUS$7,737Anhco NguyenIndividual10,746US$0.72
16 Nov 23SellUS$1,271Jill HenrichIndividual3,267US$0.39
16 Nov 23SellUS$4,652Eric HyllengrenIndividual11,958US$0.39
16 Nov 23SellUS$3,231K. MuruganIndividual8,307US$0.39
16 Nov 23SellUS$7,939Pascal TouchonIndividual20,409US$0.39
16 Nov 23SellUS$4,780Manher JoshiIndividual12,287US$0.39
16 Nov 23SellUS$3,445Anhco NguyenIndividual8,856US$0.39
14 Nov 23BuyUS$68,214Carol GallagherIndividual270,000US$0.31
10 Nov 23BuyUS$25,330William HeidenIndividual100,000US$0.25
10 Nov 23BuyUS$101,340Eric DobmeierIndividual446,825US$0.23
16 Aug 23SellUS$5,531Jill HenrichIndividual3,346US$1.65
16 Aug 23SellUS$11,526Manher JoshiIndividual6,975US$1.65
16 Aug 23SellUS$14,330K. MuruganIndividual8,672US$1.65
16 Aug 23SellUS$24,997Anhco NguyenIndividual15,126US$1.65
16 Aug 23SellUS$50,835Pascal TouchonIndividual30,766US$1.65
16 Aug 23SellUS$13,527Eric HyllengrenIndividual8,186US$1.65
27 Jun 23SellUS$23,723Pascal TouchonIndividual14,291US$1.66
16 May 23SellUS$17,089K. MuruganIndividual8,389US$2.04
16 May 23SellUS$38,784Charlene BanardIndividual19,040US$2.04
16 May 23SellUS$16,131Eric HyllengrenIndividual7,918US$2.04
16 May 23SellUS$60,633Pascal TouchonIndividual29,766US$2.04

Insider Trading Volume

Insider Buying: ATRA insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of ATRA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies20,3000.017%
Individual Insiders1,868,3921.57%
Hedge Funds26,901,57122.5%
General Public40,767,12934.2%
Institutions49,801,83841.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.5%.


Top Shareholders

Top 25 shareholders own 59.96% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.63%
Redmile Group, LLC
10,301,409US$7.4m64%0.31%
8.43%
EcoR1 Capital, LLC
10,067,043US$7.2m0%0.23%
5.94%
BlackRock, Inc.
7,087,213US$5.1m-7.91%no data
5.6%
The Vanguard Group, Inc.
6,686,043US$4.8m1.21%no data
5.47%
Citadel Advisors LLC
6,533,119US$4.7m2,380%no data
3.09%
UBS Asset Management AG
3,693,225US$2.6m6,210%no data
2.46%
AQR Capital Management, LLC
2,930,283US$2.1m247%no data
2.45%
Millennium Management LLC
2,920,980US$2.1m793%no data
2.33%
State Street Global Advisors, Inc.
2,784,200US$2.0m10.4%no data
1.8%
Geode Capital Management, LLC
2,150,150US$1.5m3.54%no data
1.7%
JP Morgan Asset Management
2,026,116US$1.4m-75.9%no data
1.57%
Kleiner Perkins Caufield & Byers
1,876,650US$1.3m0%0.26%
1.49%
Morgan Stanley, Investment Banking and Brokerage Investments
1,779,960US$1.3m-12.2%no data
1.48%
Acadian Asset Management LLC
1,765,554US$1.3m230%no data
0.92%
Medical Strategy GmbH, Asset Management Arm
1,097,247US$784.2k-1.79%0.05%
0.87%
D. E. Shaw & Co., L.P.
1,033,992US$739.0k-73.6%no data
0.84%
Antipodean Advisors LLC
1,000,000US$714.7k0%3.4%
0.84%
Staley Capital Advisers, Inc.
1,000,000US$714.7k0%0.03%
0.71%
Northern Trust Global Investments
845,427US$604.2k5.82%no data
0.66%
GSA Capital Partners LLP
784,367US$560.6k0%0.05%
0.65%
Jacobs Levy Equity Management Inc
780,986US$558.2k37.8%no data
0.62%
Charles Schwab Investment Management, Inc.
745,145US$532.6k0%no data
0.52%
Renaissance Technologies LLC
622,911US$445.2k-24.9%no data
0.45%
Goldman Sachs Group, Investment Banking and Securities Investments
536,269US$383.3k-86.8%no data
0.44%
Pacific Heights Asset Management, LLC
525,000US$375.2k0%0.03%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.